Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Agilent Technologies Inc.

< Previous 1 2 3 4 5 6 7 8 Next >
Agilent to Webcast First-Quarter Fiscal Year 2022 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Presents Thought Leader Award to Professor Jason Kovacic
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Present at Evercore ISI Virtual Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces Thought Leader Award to David R. Liu at the Broad Institute
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Present at Wells Fargo Virtual Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Reports Third-Quarter Fiscal Year 2021 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Researchers Develop COVID-19 Severity Screening Method Based on the Agilent Cary 630 FTIR Spectrometer
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Earns 2021 Great Place to Work Certification in the U.S.
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces Target Enrichment Manufacturing Facility in China
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Early Career Professor Award Presented to Jason H. Yang
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Clinical Utility of ALK Fusion Detection by Liquid Biopsy
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Webcast Third-Quarter Fiscal Year 2021 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC)
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces Optimized and Verified Method for Testing Over 100 PFAS Compounds
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Resolution Bioscience (a part of Agilent) Investigated Acquired Resistance to KRAS G12C Inhibition
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Completes the InfinityLab Bio LC Portfolio
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Presents Thought Leader Award to Dr. Stéphane Bayen
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces New SureSelect Human All Exon V8
From Agilent Technologies Inc.
Via Business Wire
Tickers A
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.